Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication 
XL413
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
ZINC1775962367
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
ZINC4326719
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
ZINC4511851
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
ZINC95559591
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Zotatifin
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Sanglifehrin A
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Sapanisertib
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Ternatin 4
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Tigecycline
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
Tomivosertib
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Valproic Acid
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
Pevonedistat
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
PS3061
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
RS-PPCC
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
MZ1
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
PB28
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
PD-144418
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
JQ1
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Linezolid
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020